Gelonghui, May 16, 丨 Jin Dawei (002626.SZ) held a performance briefing on May 16, 2024 to discuss “What products are the synthetic biotechnology currently used in the company, and what new products does it plan to use synthetic biotechnology to develop in the future?” The company replied that the company has used synthetic biotechnology in the production of products such as coenzyme Q10, NMN, NADH, vitamin K2, nattokinase, PQQ, adenosylmethionine, DHA, ARA, etc., and also uses synthetic biology to lay out new products, such as astaxanthin, inositol, calcium pantothenate, etc. In the future, the company will use synthetic biotechnology to lay out biosaccharide series products such as allodonose and tag sugar.
金达威(002626.SZ)：未来将利用合成生物技术布局生物代糖
Kim Dawei (002626.SZ): In the future, synthetic biotechnology will be used to lay out biosaccharides
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.